Cas:3572-74-5 2-(1,1-Diphenylethoxy)-N,N-dimethylethanamine manufacturer & supplier

We serve Chemical Name:2-(1,1-Diphenylethoxy)-N,N-dimethylethanamine CAS:3572-74-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(1,1-Diphenylethoxy)-N,N-dimethylethanamine

Chemical Name:2-(1,1-Diphenylethoxy)-N,N-dimethylethanamine
CAS.NO:3572-74-5
Synonyms:Spofa 325;Theadrylettae;Mephenhydramine;Mephenhydraminum;Moxastine;Therdryl;Moxastin
Molecular Formula:C18H23NO
Molecular Weight:269.38100
HS Code:2922199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:357.5ºC at 760mmHg
Density:1.013g/cm3
Index of Refraction:1.542
PSA:12.47000
Exact Mass:269.17800
LogP:3.52830

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Spofa 325 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Moxastin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Spofa 325 Use and application,Therdryl technical grade,usp/ep/jp grade.


Related News: By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names. 2-(1,1-Diphenylethoxy)-N,N-dimethylethanamine manufacturer The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen��s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination. 2-(1,1-Diphenylethoxy)-N,N-dimethylethanamine supplier By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names. 2-(1,1-Diphenylethoxy)-N,N-dimethylethanamine vendor Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. 2-(1,1-Diphenylethoxy)-N,N-dimethylethanamine factory The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen��s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination.